MedTrace Logo

A Multilevel Approach to Connecting Underrepresented Populations to Clinical Trials

NCT05655494 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 350

Last updated 2026-05-08

No results posted yet for this study

Summary

The purpose of this study is to pilot test and evaluate an existing tailored ALEX (Agent Leveraging Empathy for eXams) Research Portal to navigate Black and Hispanic adult cancer patients and their family members through referral to cancer clinical trials.

Conditions

Interventions

BEHAVIORAL

Stand-alone Research Portal

The standard of care condition will include a portal that provides patients with access to existing online cancer clinical trial resources in one location. This includes links to pages with basic information about cancer clinical trials, ongoing studies, enrollment opportunities for existing institutional research registries, and contact information for study coordinators.

BEHAVIORAL

Portal with Virtual Community Health Educator (vCHE)

The virtual community health educator condition will provide all information in standard of care with the addition of a virtual community health educator. Patients will have the opportunity to choose which virtual community health educator will provide digital navigation. The choices will include at least four English-speaking and four Spanish-speaking virtual community health educators representing different genders and racial/ethnic backgrounds.

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • University of Florida

    lead OTHER

Principal Investigators

  • Janice Krieger, PhD · Mayo Clinic

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-05-20
Primary Completion
2027-08-31
Completion
2027-08-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05655494 on ClinicalTrials.gov